Embera Management Team
- Robert B. Linke
- Carol A. Gloff, Ph.D.
- Douglas Feltner, M.D.
- Barbara Fox, Ph.D.
- Nicholas Goeders, Ph.D.
- Michael Short
Embera Board of Directors
Scientific Advisory Board
- George Koob, Ph.D.
- Charles O'Brien, MD, Ph.D.
- Bruce McCarthy, MD
- Kathleen Brady, MD, Ph.D.
- Rajita Sinha, Ph.D.
Investors
Robert B. Linke - President and Chief Executive Officer, Director
Mr. Linke joined Embera NeuroTherapeutics in 2009 as its CEO. Prior to joining Embera, he provided consulting services to a range of growing life science companies including Allscripts, a leading pharmaceutical e-marketing company, where he led their Physicians Interactive Division. Prior to this venture, Mr. Linke was President & CEO of two development stage life science companies - Rapid Micro Biosystems and Periodontix. At Rapid Micro Biosystems he developed and executed the strategy to commercialize imaging-based rapid microbiology testing systems for pharma and biotech manufacturers that are now being sold to the industry. At Periodontix, Inc., a venture-backed biopharmaceutical company, he led the effort to develop a portfolio of antimicrobial products and sold the company after advancing the lead compound through Phase 2 studies. Mr. Linke also has an extensive business leadership background that includes senior sales, marketing and general management positions at leading healthcare companies that include Baxter International, Caremark International and Sunstar Inc. (Japan). Mr. Linke holds BA degrees in Economics and Mathematics from Albion College and an MBA from the Harvard Business School.